JP Mangeolle is a member of the Board of Directors of TeraPore. He has more than 35 years of experience in life sciences and bioscience building teams and profitable businesses across the globe in multiple market segments, including biotechnology and pharmaceutical companies, academic research laboratories, microelectronics manufacturing, and original equipment manufacturing (OEM) companies. He retired recently from Sciex Group (an operating company of Danaher Corp.), where he had held the position of President since 2014. Previously, he was Executive Vice President for the Process Solutions Business Unit of Merck KGaA Millipore. Mr. Mangeolle spent more than 25 years with Millipore in positions of increasing responsibility, culminating in the role of President of the Bioprocess Division. He was also a member of Millipore’s Corporate Executive Committee and an elected corporate officer.
Mr. Mangeolle is a board member of Charles River Labs and Gelest, Inc., and is a co-founder of Petri Bio, an early stage venture capital firm.